Since it was demonstrated that HNSCC tumors that express intensive EpCAM have worse prognosis after primary radiation therapy, it will be interesting to compare clinical outcome of primary surgery followed by postoperative radiation therapy to that of primary radiation therapy for this population of patients in future studies. The gene discussed is EPCAM; the disease is head and neck squamous cell carcinoma.